SOLBAR NINGBO PROTEIN TECH CO L (603231.SS)
CNY 17.06
(-1.56%)
CNY 17.06
(-1.56%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 239.4 Million CNY | -10.1% |
| 2022 | 248.07 Million CNY | 26.15% |
| 2021 | 190.75 Million CNY | 23.5% |
| 2020 | 165.52 Million CNY | 27.96% |
| 2019 | 130.77 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 24.65 Million CNY | -55.86% |
| 2024 Q1 | 40.46 Million CNY | 18.08% |
| 2024 Q2 | 34.79 Million CNY | 22.84% |
| 2023 Q3 | 56.43 Million CNY | 117.48% |
| 2023 FY | - CNY | -10.1% |
| 2023 Q4 | 38.49 Million CNY | -31.78% |
| 2023 Q2 | -322.82 Million CNY | -1228.0% |
| 2023 Q1 | 28.61 Million CNY | 299.12% |
| 2022 Q4 | -14.37 Million CNY | 0.0% |
| 2022 FY | - CNY | 26.15% |
| 2021 FY | - CNY | 23.5% |
| 2020 FY | - CNY | 27.96% |
| 2019 FY | - CNY | 0.0% |